#87FUZKK atlas leaders 1–100
Telix Pharmaceuticals
Australia · Australia and New Zealand
Peptides and complex injectablesOncology / ADC / high-potencyRadiopharmaceuticals
Manufacturing profile
Peptides and complex injectables
Oncology / ADC / high-potency
Radiopharmaceuticals
Country: Australia
Macro-region: Australia and New Zealand
Selection basis
The company is placed in positions 1–100 as a major manufacturer, biopharmaceutical group, generics/API/CDMO leader or a significant regional manufacturing participant.
The Top 300 is a FUZKK atlas priority rather than a single official revenue table. China, India, Israel, the USA and the European scope are excluded because separate atlases already cover them.
Representative manufacturing and QC chain
- 1Peptide synthesis or recombinant upstream
- 2Chromatography and UF/DF
- 3HPLC/LC-MS and CE peptide mapping
- 4Sterile filtration and cartridge/vial filling
- 5Particles, sterility, endotoxin and cold-chain release
- 6Contained dispensing and high-potency handling
- 7Chemical synthesis or biologic upstream
- 8Purification and formulation
- 9HPLC/LC-MS/CE and potency analytics
Relevant FUZKK packages
Product/API utilities
Insulin Analog Impurity CheckerHuman Insulin Quality CheckerGLP1 Injectable Release CheckerADC Aggregation MonitorADC Drug Antibody Ratio AnalyzerADC Free Payload QuantifierADC Linker Stability ProfilerADCRelease Readiness CheckerRadionuclidic Purity CheckerCold Chain Shipping Temperature And MKT Quality Checker
Lumex — instrumental QC
LabEx — laboratory QC
Medical Devices — equipment and software lifecycle
Suggested first pilot
- Confirm one real product, method or recurring QC review.
- Record the instrument, export format and current specification.
- Select 3–7 utilities from the map above.
- Run a PASS/FAIL sample and agree the expected output.
- After user validation, expand to other products and sites.
Mapping boundary
The Top 300 is a FUZKK atlas priority rather than a single official revenue table. China, India, Israel, the USA and the European scope are excluded because separate atlases already cover them.
Methodology